Understanding the intricacies of cellular senescence in atherosclerosis : Mechanisms and therapeutic implications

Copyright © 2024 Elsevier B.V. All rights reserved..

Cardiovascular disease is currently the largest cause of mortality and disability globally, surpassing communicable diseases, and atherosclerosis is the main contributor to this epidemic. Aging is intimately linked to atherosclerosis development and progression, however, the mechanism of aging in atherosclerosis is not well known. To emphasize the significant research on the involvement of senescent cells in atherosclerosis, we begin by outlining compelling evidence that indicates various types of senescent cells and SASP factors linked to atherosclerotic phenotypes. We subsequently provide a comprehensive summary of the existing knowledge, shedding light on the intricate mechanisms through which cellular senescence contributes to the pathogenesis of atherosclerosis. Further, we cover that senescence can be identified by both structural changes and several senescence-associated biomarkers. Finally, we discuss that preventing accelerated cellular senescence represents an important therapeutic potential, as permanent changes may occur in advanced atherosclerosis. Together, the review summarizes the relationship between cellular senescence and atherosclerosis, and inspects the molecular knowledge, and potential clinical significance of senescent cells in developing senescent-based therapy, thus providing crucial insights into their biology and potential therapeutic exploration.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:96

Enthalten in:

Ageing research reviews - 96(2024) vom: 28. Apr., Seite 102273

Sprache:

Englisch

Beteiligte Personen:

Ali, Ilyas [VerfasserIn]
Zhang, Hongliang [VerfasserIn]
Zaidi, Syed Aqib Ali [VerfasserIn]
Zhou, Guangqian [VerfasserIn]

Links:

Volltext

Themen:

Atherosclerosis
Biomarkers
Cardiovascular disease
Cellular senescence
Journal Article
Review
SASP factors
Therapeutic amplification

Anmerkungen:

Date Completed 15.04.2024

Date Revised 15.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.arr.2024.102273

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369824873